Holista Colltech Limited (ASX:HCT)

Australia · Delayed Price · Currency is AUD

0.0690

+0.0040 (6.15%)

Apr 29, 2026, 3:06 PM AEST

60.47% (1Y)

Market Cap	23.91M
Revenue (ttm)	5.79M
Net Income (ttm)	-948.92K
Shares Out	367.83M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,002,423
Average Volume	123,676
Open	0.0650
Previous Close	0.0650
Day's Range	0.0650 - 0.0690
52-Week Range	0.0350 - 0.1100
Beta	1.28
RSI	51.54
Earnings Date	May 29, 2026

About Holista Colltech

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it provides GI LiTE, a premix glycemi... [Read more]

Industry Packaged Foods

Sector Consumer Staples

CEO Leong Loong

Employees 58

Stock Exchange Australian Securities Exchange

Ticker Symbol HCT

Full Company Profile

Financial Performance

In 2025, Holista Colltech's revenue was 5.79 million, an increase of 3.08% compared to the previous year's 5.61 million. Losses were -948,921, 1026.8% more than in 2024.

Financial Statements

News

There is no news available yet.